Trial Profile
Identification of Mechanisms in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary) ; Deferoxamine (Primary)
- Indications Anaemia; Aplastic anaemia; Myelodysplastic syndromes; Myelofibrosis
- Focus Pharmacodynamics
- Acronyms BIOFER12
- 14 Feb 2023 Status changed from active, no longer recruiting to completed.
- 29 Jul 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 21 Jun 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.